CN1103587A - Pills for leukodermia - Google Patents

Pills for leukodermia Download PDF

Info

Publication number
CN1103587A
CN1103587A CN 93115621 CN93115621A CN1103587A CN 1103587 A CN1103587 A CN 1103587A CN 93115621 CN93115621 CN 93115621 CN 93115621 A CN93115621 A CN 93115621A CN 1103587 A CN1103587 A CN 1103587A
Authority
CN
China
Prior art keywords
radix
grams
pill
weight ratio
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 93115621
Other languages
Chinese (zh)
Inventor
张祖球
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 93115621 priority Critical patent/CN1103587A/en
Publication of CN1103587A publication Critical patent/CN1103587A/en
Pending legal-status Critical Current

Links

Abstract

Medicinal materials including asiabell root, Chinese angelica, Astragalus, red sage, root bark of tree peony, paeonia lactiflora, etc. are mixed and ground to powder, which is then mixed with honey to produce the said leudodermia pill. The said pill can eliminate white plaque and restore normal skin colour with an effective rate of 96.66% and a curative rate of 77.33%.

Description

Pills for leukodermia
The present invention is a kind of treatment leucoderma disease pill.
Vitiligo is a kind of pigment obstacle disease, can still belong to rarely by the clinical this dermopathic medicine of healing vitiligo of executing in the known technology.
The purpose of this invention is to provide a kind of oral pills that can effectively treat leucoderma disease.
The present invention realizes like this, use Radix Codonopsis, Radix Angelicae Sinensis, the Radix Astragali, Radix Salviae Miltiorrhizae, Cortex Moutan, Flos Carthami, Radix Paeoniae Rubra, Fructus Psoraleae, Fructus Ligustri Lucidi, the north Qi, Radix Polygalae, the five tastes, Semen Ziziphi Spinosae, Radix Saposhnikoviae, Radix Glycyrrhizae is a raw material, press 3-9: 3-9: 3-9: 3-9: 3-9: 1-5: 3-9: 2-6: 3-9: 3-9: 4-11: 4-11: 4-11: 3-9 successively: 2-6 weight ratio compatibility, be total to the levigation end, press 7-24 with this powder and Mel again: 12-38 weight ratio compatibility mf mass pil, patients with vitiligo is taken this pill, clinical executing controlled effective percentage 96.66%, cure rate 77.33%, there is not the effect of paying, patient's no pain, white macula disappears, and it is normal that color of the leather recovers.
Embodiment: Radix Codonopsis 12 gram, Radix Angelicae Sinensis 12 grams, the Radix Astragali 12 grams, Radix Salviae Miltiorrhizae 12 grams, Cortex Moutan 12 grams, Flos Carthami 6 grams, Radix Paeoniae Rubra 12 grams, Fructus Psoraleae 8 grams, Fructus Ligustri Lucidi 12 grams, northern Qi 12 grams, Radix Polygalae 9 grams, the five tastes 9 grams, Semen Ziziphi Spinosae 9 grams, Radix Saposhnikoviae 12 grams, Radix Glycyrrhizae 4 grams mix levigation end altogether, mix 250 gram Mel and evenly make a kind of treatment leucoderma disease pill of the present invention with the gained powder then.

Claims (1)

1, a kind of treatment leucoderma disease pill, it is characterized in that it is is raw material with Radix Codonopsis, Radix Angelicae Sinensis, the Radix Astragali, Radix Salviae Miltiorrhizae, Cortex Moutan, Flos Carthami, Radix Paeoniae Rubra, Fructus Psoraleae, Fructus Ligustri Lucidi, northern Qi, Radix Polygalae, the five tastes, Semen Ziziphi Spinosae, Radix Saposhnikoviae, Radix Glycyrrhizae, press 3-9: 3-9: 3-9: 3-9: 3-9: 1-5: 3-9: 2-6: 3-9: 3-9: 4-14: 4-14: 4-14: 3-9 successively: 2-6 weight ratio compatibility, 7-24 is pressed with this powder and Mel: 12-38 weight ratio compatibility mf mass pil again in the levigation end altogether.
CN 93115621 1993-12-10 1993-12-10 Pills for leukodermia Pending CN1103587A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 93115621 CN1103587A (en) 1993-12-10 1993-12-10 Pills for leukodermia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 93115621 CN1103587A (en) 1993-12-10 1993-12-10 Pills for leukodermia

Publications (1)

Publication Number Publication Date
CN1103587A true CN1103587A (en) 1995-06-14

Family

ID=4991188

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 93115621 Pending CN1103587A (en) 1993-12-10 1993-12-10 Pills for leukodermia

Country Status (1)

Country Link
CN (1) CN1103587A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1054767C (en) * 1995-12-25 2000-07-26 刘永学 Pharmaceutical preparation for treatment of leukoderma
CN1081463C (en) * 1998-01-06 2002-03-27 宋守金 External use medicine for vitiligo
CN101897933A (en) * 2010-07-18 2010-12-01 陈福正 Chinese patent medicament for treating leucoderma
CN114796372A (en) * 2021-01-27 2022-07-29 保定华仁白癜风医院 Double-vine whitening-removing pill

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1054767C (en) * 1995-12-25 2000-07-26 刘永学 Pharmaceutical preparation for treatment of leukoderma
CN1081463C (en) * 1998-01-06 2002-03-27 宋守金 External use medicine for vitiligo
CN101897933A (en) * 2010-07-18 2010-12-01 陈福正 Chinese patent medicament for treating leucoderma
CN101897933B (en) * 2010-07-18 2012-07-04 陈福正 Chinese patent medicament for treating leucoderma
CN114796372A (en) * 2021-01-27 2022-07-29 保定华仁白癜风医院 Double-vine whitening-removing pill

Similar Documents

Publication Publication Date Title
CN100536885C (en) Medicine for treating phalacrosis and restoring hair
CN1651064A (en) Medicinal composition for treating tumour and its preparation method
CN101884696A (en) Honeyed pill formulation capable of promoting hair to be regenerated and hair to become black
CN102389389A (en) Natural Chinese medicine mask for whitening skin and removing speckles
CN1739774A (en) Spot eliminating and youthful looks preserving capsule
CN1312102A (en) Life essence-filling, marrow-benefitting and kidney invigorating Chinese medicine preparation
CN104337974A (en) Drug for treating metrorrhagia and preparation method thereof
CN102068661A (en) Chinese medical formula for treating female blood stasis, blood deficiency and deep thready pulse dysmenorrhea
CN1087267A (en) A kind of prescription for the treatment of seborrheic alopecia
CN1164317C (en) Zaizao Pill for treating woman diseases
CN1181959A (en) Yin nourishing bolus for curing women's blood deficiency
CN101049340A (en) Composition of medication for treating leucoderma, and preparation method
CN1085089C (en) Traditional Chinese medicine for promoting blood circulation by removing blood stasis
CN1103587A (en) Pills for leukodermia
CN1050046C (en) Preparation method for medicine to cure flaccid paralysis
CN1408383A (en) Pure traditional Chinese medicine preparation for curing gastroinstestinal cancer and preparing method
CN1175894C (en) Medicinal plaster for treating algomenorrhea and regulating menstrual function
CN1351872A (en) Chinese herbal medicine for curing comedo and acne
CN1073861C (en) External use medicinal bag for treating acute and chronic gastritis and cholecystitis, and preparing method thereof
CN1229665A (en) Hair growth agent
CN1274348C (en) Production process of hair restorer bolus
CN1091963A (en) Freckle-removing beauty drug
CN1101566A (en) Preparing method for hemopiesic capsule
CN1126608A (en) External-use medicine bag for curing chronic gastritis and its prodn process
CN100423769C (en) Chinese medicine for treating coronary heart disease

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication